Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT06342570
Recruiting Observational

Quantitative Analysis of EEG Changes in Response to Nociception

NCT06342570 · tracked via the Priya Life Science South Korea tracker
Sponsor
Gangnam Severance Hospital
Phase
Observational
Started
2024-04-21
Last updated
2024-04-30

Condition(s) studied

Patients Undergoing Laparoscopic Surgery

Investigational drug(s) / intervention(s)

There is no Intervention name to describe.

There is no Intervention name to describe.: There is no Intervention name to describe.

Study summary

This study will quantify the nociception using Analgesia Nociception Index (ANI) during general anesthesia and analyze the differences in EEG depending on the degree of nociception. Additionally, the investigators will quantify the nociception during recovery and analyze the differences in EEG depending on the degree of nociception.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: • Patients aged ≥ 19 undergoing laparoscopic surgery Exclusion Criteria: * Patients with arrhythmia * Patients with pacemaker implantation * Patients who have received a heart transplant * Patients taking medications that may affect ANI (antimuscarinics, alpha-agonist, beta blockers, etc.) * Patients with central nervous system disease (dementia, stroke, epilepsy, brain tumor, psychiatric disease, etc.) * Patients who cannot understand the consent form

Primary outcome measure(s)

  • Correlation between changes in ANI and EEG band power in response to surgical stimulation. — When the laparoscope is inserted
    Correlation between changes in ANI and EEG band power in response to surgical stimulation

Trial sites (1)

FacilityCityRegionStatus
GangnamSeverance Hospital Seoul South Korea Recruiting

More Gangnam Severance Hospital trials in South Korea

Comparison of Full Robotic Instrumentation and Assistant-Controlled Laparoscopic Instrumentation in Robotic Distal Gastrectomy Recruiting
Pilot Study for High Output Drainage Removal After Gastrectomy Recruiting
Wearable Ambulatory Vs. Office BP in Hemodialysis Starting soon
EEG and ANI Guided Anesthesia and Quality of Recovery Recruiting
Frontal Alpha Asymmetry and Pediatric Emergence Delirium Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06342570 on ClinicalTrials.gov ↗ ← All trials in South Korea